삼성서울병원

Ko En

obstetrics and gynecology Kim, Byoung Gie M.D

TITLE
Professor,Department of Obstetrics and Gynecology, Sungkyunkwan University School of Medicine
Treament Schedule 12 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 01 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
MON
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Guest researcher National Cancer Institute, Bethesda, MD, USA

Participation in Academic Societies
and Research

Active Member of American Association for Cancer Research
Active Member of International Gynecological Cancer Society
Member of Scientific Committee of Korean Cancer Association
Member of Scientific Committee of Korean Society of Gynecologic Oncology and Colposcopy
Active Member of Korean Society of Obstetics and Gynecology

Selected Publications

  • LANCET ONCOL 2020 Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer interim results of a single-arm, phase 2 trial Youn1, JW; Hur, SY; Woo, JW; Kim, YM; Lim, MC; Park, SY; Seo, SS; No, JH; Kim, BG; Lee, JK; Shin, SJ; Kim, K; Chaney, MF; Choi, YJ; Suh, YS; Park, JS; Sung, YC
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • CANCERS 2020 10.3390/cancers12113188 Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041) Choi1, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY
    View PubMed
  • YONSEI MED J 2020 10.3349/ymj.2020.61.11.935 Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer Shin1, W; Noh, JJ; Seo, SS; Kang, S; Choi, CH; Park, SY; Kim, BG; Lim, MC
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557 Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer Choi1, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG
    View PubMed